Seeking Alpha

Watson Pharmaceuticals (WPI +6.6%) gets a lift today after agreeing to acquire Swiss rival...

Watson Pharmaceuticals (WPI +6.6%) gets a lift today after agreeing to acquire Swiss rival Actavis. The purchase gives the company a boost in the global rankings of generic drug makers to the number 3 spot. Citigroup upgrades the stock to Buy on the news.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs